monocrotaline and nadp
monocrotaline has been researched along with nadp in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Curti, C; Dorta, DJ; dos Santos, AB; Maioli, MA; Mingatto, FE; Pestana, CR | 1 |
| Dai, J; Zhang, F; Zheng, J | 1 |
Other Studies
2 other study(ies) available for monocrotaline and nadp
| Article | Year |
|---|---|
Dehydromonocrotaline induces cyclosporine A-insensitive mitochondrial permeability transition/cytochrome c release.
Topics: Alkylating Agents; Animals; Apoptosis; Calcium; Cyclosporine; Cytochromes c; Glutathione; Hydrogen Peroxide; Immunosuppressive Agents; In Vitro Techniques; Lipid Peroxidation; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Swelling; Monocrotaline; NADP; Permeability; Rats; Rats, Wistar; Sulfhydryl Compounds | 2009 |
Retrorsine, but not monocrotaline, is a mechanism-based inactivator of P450 3A4.
Topics: Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Dextromethorphan; Glutathione; Humans; Monocrotaline; NADP; Pyrrolizidine Alkaloids | 2010 |